Skip to content

Clinical trials

Phase 1/2 Asthma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 1/2 Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20064
20072
20085
20094
20104
20112
20123
20132
20142
20151
20162
20171
20181
20192
20201
20212
20223
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated9
Withdrawn5
Unknown status3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amphastar Pharmaceuticals, Inc.4
National Institute of Allergy and Infectious Diseases (NIAID)3
University of North Carolina, Chapel Hill3
Arrowhead Pharmaceuticals2
Chiesi Farmaceutici S.p.A.2
Novartis2
Novartis Pharmaceuticals2
Air Liquide SA1
Albert Einstein College of Medicine1
Aquilon Pharmaceuticals S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma49
Pulmonary Disease, Chronic Obstructive5
Hypersensitivity3
Respiratory Sounds3
Rhinitis, Allergic3
Rhinitis, Allergic, Perennial3
Dyspnea2
Asthma, Exercise-Induced1
Bronchial Spasm1
Conjunctivitis, Allergic1

Trials

Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.